?:abstract
|
-
Initial reports have suggested that COVID-19 SARS 2 virus is more prevalent and is associated with increased severity in people with diabetes (1) In a recent large series from the USA, diabetes mellitus was present as a comorbidity in over a third of patients hospitalized with COVID-19 (2) In a study of 658 hospitalized patients with confirmed COVID-19, three developed diabetic ketoacidosis (DKA) (3) Clinical experience during the COVID-19 crisis suggests that DKA and hyperglycaemic hyperosmolar syndrome (HHS) are common in people with COVID-19 infection, and are associated with significant insulin resistance, dehydration and acute kidney injury
|